Evidence map›Paper›PMID 32209661›Full record

ArticleThe Journal of rheumatology2020

The Rheumatologist's Role in COVID-19.

Randy Q Cron, W Winn Chatham

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in The Journal of rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Large language models and rheumatology: are we there yet?Rheumatology advances in practice · 2025
    Review
  4. Treatment of multisystem inflammatory syndrome in children.World journal of pediatrics : WJP · 2024
    Review
  5. IL-1 Family Blockade in Cytokine Storm Syndromes.Advances in experimental medicine and biology · 2024
    Review
  6. Cancer management during the COVID-19 world pandemic.Cancer immunology, immunotherapy : CII · 2023
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Pediatric Rheumatologic Effects of COVID-19.Pediatric clinics of North America · 2021
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Randy Q CronUniversity of Alabama at Birmingham, Department of Pediatrics, Division of Rheumatology; rcron@peds.uab.edu.ORCID 0000-0003-2661-3086
W Winn ChathamUniversity of Alabama at Birmingham, Department of Medicine, Division of Clinical Immunology and Rheumatology, Birmingham, Alabama, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Physician's RoleRheumatologistsCoronavirus InfectionsCOVID-19CytokinesHumansPandemicsPneumonia, ViralRheumatic DiseasesCytokines

Identifiers

PMID32209661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.